Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Bio N Tech Se Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $83.4 Billion
- Q1 2025
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Bio N Tech Se stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 478,257 shares of BNTX stock, worth $51 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
478,257
Previous 501,897
4.71%
Holding current value
$51 Million
Previous $57.2 Million
23.85%
% of portfolio
0.05%
Previous 0.06%
Shares
23 transactions
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$871 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$455 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$432 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$202 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$193 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...